A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)

PHASE2UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Relapsed / Refractory Follicular Lymphoma
Interventions
DRUG

TQ-B3525

TQ-B3525 tablet administered 20mg orally, once daily in 28-day cycle.

Trial Locations (41)

300000

RECRUITING

Tianjin People's Hospital, Tianjin

350000

NOT_YET_RECRUITING

Fujian Medical University Union Hospital, Fuzhou

NOT_YET_RECRUITING

Fujian Provincial Cancer Hospital, Fuzhou

450008

NOT_YET_RECRUITING

Henan Cancer Hospital, Zhengzhou

510050

RECRUITING

Sun-Yat-Sen University Cancer Center, Guangzhou

570216

NOT_YET_RECRUITING

The First Affiliated Hospital of Hainan Medical College, Haikou

650100

NOT_YET_RECRUITING

First People's Hospital of Yunnan Province, Kunming

730050

NOT_YET_RECRUITING

Gansu Cancer Hospital, Lanzhou

Unknown

NOT_YET_RECRUITING

The First Affiliated Hospital of Anhui Medical University, Hefei

NOT_YET_RECRUITING

Beijing Luohe Hospital, Capital Medical University, Beijing

NOT_YET_RECRUITING

Beijing Shijitan Hospital, Beijing

NOT_YET_RECRUITING

Beijing Tsinghua Chang Gung Hospital, Beijing

NOT_YET_RECRUITING

Chinese People's Liberation Army General Hospital, Beijing

NOT_YET_RECRUITING

Fifth Medical Center of General Hospital of Chinese People's Liberation Army, Beijing

NOT_YET_RECRUITING

Peking University People's Hospital, Beijing

NOT_YET_RECRUITING

The Sixth Medical Center of General Hospital of Chinese People's Liberation Army, Beijing

NOT_YET_RECRUITING

Xuanwu Hospital of Capital Medical University, Beijing

NOT_YET_RECRUITING

First Affiliated Hospital of Xiamen University, Xiamen

NOT_YET_RECRUITING

Chinese People's Liberation Army Joint Logistics Support Unit 940 Hospital, Lanzhou

NOT_YET_RECRUITING

Foshan First People's Hospital, Foshan

NOT_YET_RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

NOT_YET_RECRUITING

Guangzhou First People's Hospital, Guangzhou

NOT_YET_RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

NOT_YET_RECRUITING

Cancer Hospital of Guangxi Medical University, Nanning

NOT_YET_RECRUITING

The Second Affiliated Hospital of Hainan Medical College, Haikou

NOT_YET_RECRUITING

The Fourth Hospital of Hebei Medical University, Shijiazhuang

NOT_YET_RECRUITING

Henan Provincial People's Hospital, Zhengzhou

NOT_YET_RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

NOT_YET_RECRUITING

Affiliated Hospital of Inner Mongolia Medical University, Hohhot

NOT_YET_RECRUITING

Jiangsu Provincial Cancer Hospital, Nanjing

NOT_YET_RECRUITING

Affiliated Zhongshan Hospital of Dalian University, Dalian

NOT_YET_RECRUITING

The First Affiliated Hospital of Dalian Medical University, Dalian

NOT_YET_RECRUITING

Weifang People's Hospital, Weifang

NOT_YET_RECRUITING

Weihai Central Hospital, Weihai

NOT_YET_RECRUITING

Tongji Hospital of Tongji University, Shanghai

NOT_YET_RECRUITING

Shanxi Provincial Cancer Hospital, Taiyuan

NOT_YET_RECRUITING

General Hospital of Tianjin Medical University, Tianjin

NOT_YET_RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

NOT_YET_RECRUITING

The Second Affiliated Hospital of Kunming Medical University, Kunming

NOT_YET_RECRUITING

Affiliated to Zhejiang University School of Medicine,Sir Run Run Shaw Hospital, Hangzhou

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY